About Syremis Therapeutics
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Tel Aviv, Israel
Year Founded
2025
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
syremis.com
Domain Registered Date
May 19, 2025
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $165,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
syremis.com
- Milestone
Company founded
Tel Aviv, Israel
Investors & Backers
Bain Capital Life Sciences
Dexcel Pharma
GV
Pictet Private Equity Investors S.A.
QVT Financial
Third Rock Ventures
Funding History
Series-A
· Dec 18, 2025
$165,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026